Dengue - Sample Collection Study Pakistan

N/ANot Yet RecruitingNCT07203183

Abbott Rapid Dx200 enrolled

Overview

The objective of this study is to collect well-characterized serum and plasma specimens from confirmed dengue positive and dengue negative subjects to support dengue diagnostic products development.

Study Type

OBSERVATIONAL

Enrollment

200

Conditions

Dengue

Eligibility

Sex: ALLMin age: 12 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Age ≥12-years-old * Individuals suspected or confirmed for active dengue, with dengue-consistent symptoms onset up to and including 10 days before enrolment in this trial. Exclusion Criteria: * Subject has been vaccinated for dengue. * Subject participates in an investigative drug, vaccine or medical device clinical study * Participant is deemed unfit for the study by the Investigator * Participant is unwilling or unable to provide informed consent

Outcomes

Primary Outcomes

sample collection only, no specific outcome needed

Time frame: 5 months

Central Contacts

Simon Kordowich, PHD

CONTACT

+353 (0)91 429 900 info@abbott.com

Jocelyn Farge, MSc, MBA

CONTACT

+353 (0)91 429 900 info@abbott.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.